<!DOCTYPE HTML>
<html lang="en">
<head>
<!-- Generated by javadoc (20) -->
<title>Source code</title>
<meta name="viewport" content="width=device-width, initial-scale=1">
<meta name="description" content="source: package: org.biopax.paxtools.model.level3, enum: ControlType">
<meta name="generator" content="javadoc/SourceToHTMLConverter">
<link rel="stylesheet" type="text/css" href="../../../../../../stylesheet.css" title="Style">
</head>
<body class="source-page">
<main role="main">
<div class="source-container">
<pre><span class="source-line-no">001</span><span id="line-1">package org.biopax.paxtools.model.level3;</span>
<span class="source-line-no">002</span><span id="line-2"></span>
<span class="source-line-no">003</span><span id="line-3"></span>
<span class="source-line-no">004</span><span id="line-4">/**</span>
<span class="source-line-no">005</span><span id="line-5"> * Defines the nature of the control relationship between the controller and the controlled entities.</span>
<span class="source-line-no">006</span><span id="line-6">*/</span>
<span class="source-line-no">007</span><span id="line-7">public enum ControlType</span>
<span class="source-line-no">008</span><span id="line-8">{</span>
<span class="source-line-no">009</span><span id="line-9">        /**</span>
<span class="source-line-no">010</span><span id="line-10">         * General activation. Compounds that activate the specified enzyme activity by an unknown mechanism. The</span>
<span class="source-line-no">011</span><span id="line-11">         * mechanism is defined as unknown, because either the mechanism has yet to be elucidated in the experimental</span>
<span class="source-line-no">012</span><span id="line-12">         * literature, or the paper(s) curated thus far do not define the mechanism, and a full literature search has</span>
<span class="source-line-no">013</span><span id="line-13">         * yet to be performed.</span>
<span class="source-line-no">014</span><span id="line-14">         */</span>
<span class="source-line-no">015</span><span id="line-15">        ACTIVATION,</span>
<span class="source-line-no">016</span><span id="line-16">        /**</span>
<span class="source-line-no">017</span><span id="line-17">         * General inhibition. Compounds that inhibit the specified enzyme activity by an unknown mechanism. The</span>
<span class="source-line-no">018</span><span id="line-18">         * mechanism is defined as unknown, because either the mechanism has yet to be elucidated in the experimental</span>
<span class="source-line-no">019</span><span id="line-19">         * literature, or the paper(s) curated thus far do not define the mechanism, and a full literature search has</span>
<span class="source-line-no">020</span><span id="line-20">         * yet to be performed.</span>
<span class="source-line-no">021</span><span id="line-21">         */</span>
<span class="source-line-no">022</span><span id="line-22">        INHIBITION,</span>
<span class="source-line-no">023</span><span id="line-23"></span>
<span class="source-line-no">024</span><span id="line-24">        /**</span>
<span class="source-line-no">025</span><span id="line-25">         * @deprecated LEVEL 1 workaround</span>
<span class="source-line-no">026</span><span id="line-26">         */</span>
<span class="source-line-no">027</span><span id="line-27">        ACTIVATION_UNKMECH,</span>
<span class="source-line-no">028</span><span id="line-28">        /**</span>
<span class="source-line-no">029</span><span id="line-29">         * @deprecated LEVEL 1 workaround</span>
<span class="source-line-no">030</span><span id="line-30">         */</span>
<span class="source-line-no">031</span><span id="line-31">        INHIBITION_UNKMECH,</span>
<span class="source-line-no">032</span><span id="line-32">        /**</span>
<span class="source-line-no">033</span><span id="line-33">         * Allosteric inhibitors decrease the specified enzyme activity by binding reversibly to the enzyme and</span>
<span class="source-line-no">034</span><span id="line-34">         * inducing a conformational change that decreases the affinity of the enzyme to its substrates without</span>
<span class="source-line-no">035</span><span id="line-35">         * affecting its VMAX. Allosteric inhibitors can be competitive or noncompetitive inhibitors, therefore,</span>
<span class="source-line-no">036</span><span id="line-36">         * those inhibition categories can be used in conjunction with this category.</span>
<span class="source-line-no">037</span><span id="line-37">         */</span>
<span class="source-line-no">038</span><span id="line-38">        INHIBITION_ALLOSTERIC,</span>
<span class="source-line-no">039</span><span id="line-39">        /**</span>
<span class="source-line-no">040</span><span id="line-40">         * Competitive inhibitors are compounds that competitively inhibit the specified enzyme activity by binding</span>
<span class="source-line-no">041</span><span id="line-41">         * reversibly to the enzyme and preventing the substrate from binding. Binding of the inhibitor and substrate</span>
<span class="source-line-no">042</span><span id="line-42">         * are mutually exclusive because it is assumed that the inhibitor and substrate can both bind only to the free</span>
<span class="source-line-no">043</span><span id="line-43">         * enzyme. A competitive inhibitor can either bind to the active site of the enzyme,</span>
<span class="source-line-no">044</span><span id="line-44">         * directly excluding the substrate from binding there, or it can bind to another site on the enzyme,</span>
<span class="source-line-no">045</span><span id="line-45">         * altering the conformation of the enzyme such that the substrate can not bind to the active site.</span>
<span class="source-line-no">046</span><span id="line-46">         */</span>
<span class="source-line-no">047</span><span id="line-47">        INHIBITION_COMPETITIVE,</span>
<span class="source-line-no">048</span><span id="line-48">        /**</span>
<span class="source-line-no">049</span><span id="line-49">         * Irreversible inhibitors are compounds that irreversibly inhibit the specified enzyme activity by binding to</span>
<span class="source-line-no">050</span><span id="line-50">         * the enzyme and dissociating so slowly that it is considered irreversible. For example, alkylating agents,</span>
<span class="source-line-no">051</span><span id="line-51">         * such as iodoacetamide, irreversibly inhibit the catalytic activity of some enzymes by modifying cysteine</span>
<span class="source-line-no">052</span><span id="line-52">         * side chains.</span>
<span class="source-line-no">053</span><span id="line-53">         */</span>
<span class="source-line-no">054</span><span id="line-54">        INHIBITION_IRREVERSIBLE,</span>
<span class="source-line-no">055</span><span id="line-55">        /**</span>
<span class="source-line-no">056</span><span id="line-56">         * Noncompetitive inhibitors are compounds that noncompetitively inhibit the specified enzyme by binding</span>
<span class="source-line-no">057</span><span id="line-57">         * reversibly to both the free enzyme and to the enzyme-substrate complex. The inhibitor and substrate may be</span>
<span class="source-line-no">058</span><span id="line-58">         * bound to the enzyme simultaneously and do not exclude each other. However, only the enzyme-substrate complex</span>
<span class="source-line-no">059</span><span id="line-59">         * (not the enzyme-substrate-inhibitor complex) is catalytically active.</span>
<span class="source-line-no">060</span><span id="line-60">         */</span>
<span class="source-line-no">061</span><span id="line-61">        INHIBITION_NONCOMPETITIVE,</span>
<span class="source-line-no">062</span><span id="line-62">        /**</span>
<span class="source-line-no">063</span><span id="line-63">         * Compounds that inhibit the specified enzyme activity by a mechanism that has been characterized,</span>
<span class="source-line-no">064</span><span id="line-64">         * but that cannot be clearly classified as irreversible, competitive, noncompetitive, uncompetitive,</span>
<span class="source-line-no">065</span><span id="line-65">         * or allosteric.</span>
<span class="source-line-no">066</span><span id="line-66">         */</span>
<span class="source-line-no">067</span><span id="line-67">        INHIBITION_OTHER,</span>
<span class="source-line-no">068</span><span id="line-68">        /**</span>
<span class="source-line-no">069</span><span id="line-69">         * Uncompetitive inhibitors are compounds that uncompetitively inhibit the specified enzyme activity by binding</span>
<span class="source-line-no">070</span><span id="line-70">         * reversibly to the enzyme-substrate complex but not to the enzyme alone.</span>
<span class="source-line-no">071</span><span id="line-71">         */</span>
<span class="source-line-no">072</span><span id="line-72">        INHIBITION_UNCOMPETITIVE,</span>
<span class="source-line-no">073</span><span id="line-73">        /**</span>
<span class="source-line-no">074</span><span id="line-74">         * Nonallosteric activators increase the specified enzyme activity by means other than allosteric.</span>
<span class="source-line-no">075</span><span id="line-75">         */</span>
<span class="source-line-no">076</span><span id="line-76">        ACTIVATION_NONALLOSTERIC,</span>
<span class="source-line-no">077</span><span id="line-77">        /**</span>
<span class="source-line-no">078</span><span id="line-78">         * Allosteric activators increase the specified enzyme activity by binding reversibly to the enzyme and</span>
<span class="source-line-no">079</span><span id="line-79">         * inducing a conformational change that increases the affinity of the enzyme to its substrates without</span>
<span class="source-line-no">080</span><span id="line-80">         * affecting its VMAX.</span>
<span class="source-line-no">081</span><span id="line-81">         */</span>
<span class="source-line-no">082</span><span id="line-82">        ACTIVATION_ALLOSTERIC</span>
<span class="source-line-no">083</span><span id="line-83">}</span>




























































</pre>
</div>
</main>
</body>
</html>
